Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

cyclin A-type Activators

Cyclin A-type Activators would represent a class of molecules that specifically increase the activity of cyclin A, a member of the cyclin family of proteins. Cyclins are regulatory proteins that control the progression of cells through the cell cycle by activating cyclin-dependent kinases (CDKs). Cyclin A exists in two forms in vertebrates: cyclin A1, which is expressed during meiosis, and cyclin A2, which is expressed during mitosis. The activators of cyclin A-type would likely function by promoting the association between cyclin A and its partner CDKs, stabilizing the complex, or enhancing its kinase activity, which is essential for the transition from the S phase to the M phase of the cell cycle. These activators could bind to cyclin A and induce conformational changes that favor its activation or could interact with the regulatory pathways that control the synthesis or degradation of cyclin A, thus affecting its cellular levels and activity.

To study cyclin A-type activators, a multidisciplinary approach involving biochemistry, cell biology, and molecular biology would be essential. Biochemical methods could include in vitro kinase assays to measure CDK activity in the presence of cyclin A and potential activators, helping to quantify the effect of these molecules on the enzymatic function of the cyclin A-CDK complex. Additionally, protein interaction assays, such as co-immunoprecipitation, could be used to assess the impact of activators on the formation and stability of the cyclin A-CDK complex. Molecular investigations might involve the use of reporter assays to determine how cyclin A-type activators influence the transcription of genes downstream of the cyclin A pathway. Furthermore, the use of synchronized cell populations would allow for the precise analysis of the effects of these activators on cell cycle progression, particularly the S to M phase transition. Through these investigative techniques, a comprehensive understanding of the mechanisms by which cyclin A-type activators modulate cyclin A function could be achieved, shedding light on the intricate control of cell cycle dynamics.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

This compound induces DNA damage, which can activate cell cycle checkpoints and potentially increase cyclin A expression as part of the DNA damage response.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Another DNA-damaging agent that can lead to activation of cell cycle checkpoints and might increase cyclin A expression as a cellular response.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

A nucleotide analog that disrupts DNA synthesis, potentially upregulating cyclin A expression as cells attempt to overcome the blockage of DNA replication.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

An inhibitor of dihydrofolate reductase that results in DNA synthesis blockade, which might trigger an upregulation of cyclin A to compensate.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

A ribonucleotide reductase inhibitor that leads to a depletion of deoxyribonucleotide pools, potentially affecting cyclin A expression.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Causes DNA crosslinks and damage, leading to cell cycle arrest, which may subsequently induce cyclin A expression as part of the cellular response.

Bleomycin

11056-06-7sc-507293
5 mg
$270.00
5
(0)

Induces DNA breaks, which activates cell cycle checkpoints and could potentially influence cyclin A expression.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$230.00
$450.00
$1715.00
$2900.00
4
(0)

A microtubule-disrupting agent that arrests cells at the G2/M phase, potentially affecting cyclin A expression as cells respond to mitotic stress.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Disrupts microtubule polymerization, causing cell cycle arrest, which may lead to changes in cyclin A expression levels.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Affects cell differentiation processes and may upregulate cyclin A expression as part of the regulation of cell proliferation.